Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Birth Defects Research. Part A, Clinical and Molecular Teratology
|
July 19, 2012
Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence
Janine E Polifka
Birth Defects Research
|
March 6, 2023
Bob Brent: Scientist, physician, scholar, teacher, mentor, and mensch
Janine E Polifka, Jay Greenspan
Toxicology
|
April 17, 2002
Developmental toxicity: web resources for evaluating risk in humans
Janine E Polifka, Elaine M Faustman
Birth Defects Research. Part A, Clinical and Molecular Teratology
|
May 17, 2003
Developmental toxicity of ribavirin/IFalpha combination therapy: is the label more dangerous than the drugs?
Janine E Polifka, J M Friedman
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
August 21, 2002
Medical genetics: 1. Clinical teratology in the age of genomics
Janine E Polifka, J M Friedman
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
|
July 19, 2011
The art and science of teratogen risk communication
Elizabeth A Conover, Janine E Polifka
Teratology
|
April 23, 2002
Teratogen update: azathioprine and 6-mercaptopurine
Janine E Polifka, J M Friedman
Birth Defects Research. Part A, Clinical and Molecular Teratology
|
October 6, 2005
Addendum: sartan treatment during pregnancy
Sura Alwan, Janine E Polifka, Jan M Friedman
Journal of the American Academy of Dermatology
|
April 16, 2008
Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases
Joseph Lam, Janine E Polifka, Magdalene A Dohil
American Journal of Medical Genetics. Part A
|
March 21, 2017
Thomas H. Shepard, M.D., pioneer in embryology and teratology
Alan G Fantel, Janine E Polifka, Godfrey P Oakley
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Birth Defects Research. Part A, Clinical and Molecular Teratology
|
July 19, 2012
Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence
Janine E Polifka
Birth Defects Research
|
March 6, 2023
Bob Brent: Scientist, physician, scholar, teacher, mentor, and mensch
Janine E Polifka, Jay Greenspan
Toxicology
|
April 17, 2002
Developmental toxicity: web resources for evaluating risk in humans
Janine E Polifka, Elaine M Faustman
Birth Defects Research. Part A, Clinical and Molecular Teratology
|
May 17, 2003
Developmental toxicity of ribavirin/IFalpha combination therapy: is the label more dangerous than the drugs?
Janine E Polifka, J M Friedman
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
August 21, 2002
Medical genetics: 1. Clinical teratology in the age of genomics
Janine E Polifka, J M Friedman
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
|
July 19, 2011
The art and science of teratogen risk communication
Elizabeth A Conover, Janine E Polifka
Teratology
|
April 23, 2002
Teratogen update: azathioprine and 6-mercaptopurine
Janine E Polifka, J M Friedman
Birth Defects Research. Part A, Clinical and Molecular Teratology
|
October 6, 2005
Addendum: sartan treatment during pregnancy
Sura Alwan, Janine E Polifka, Jan M Friedman
Journal of the American Academy of Dermatology
|
April 16, 2008
Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases
Joseph Lam, Janine E Polifka, Magdalene A Dohil
American Journal of Medical Genetics. Part A
|
March 21, 2017
Thomas H. Shepard, M.D., pioneer in embryology and teratology
Alan G Fantel, Janine E Polifka, Godfrey P Oakley
Page
of 2